Financial Summary -
Cărbunescu Clinical Research Srl
Unique identification code:28044821
Registration number:J23/367/2011
Nace:7219
Sales - Ron
11.284
Net Profit - Ron
-411
Employees
2
Open Account
Company Cărbunescu Clinical Research Srl with Fiscal Code 28044821
recorded a turnover of 2024 of
11.284,
with a net profit of
-411
and having an average number of employees of
2.
The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Cărbunescu Clinical Research Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
1.010
5.386
9.698
8.736
8.779
2.782
11.895
15.196
10.937
11.284
Total Income - EUR
1.010
5.386
9.698
8.736
8.779
2.782
11.895
15.196
10.937
11.284
Total Expenses - EUR
1.161
2.250
4.354
7.225
7.621
8.464
13.500
12.696
14.680
11.480
Gross Profit/Loss - EUR
-151
3.136
5.344
1.511
1.158
-5.683
-1.604
2.500
-3.744
-196
Net Profit/Loss - EUR
-182
3.001
5.053
1.424
1.070
-5.711
-1.723
2.348
-3.853
-411
Employees
1
1
1
1
2
2
2
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 3.8%, from 10.937 euro in the year 2023, to 11.284 euro in 2024.
Check the financial reports for the company - Cărbunescu Clinical Research Srl
Financial Rating - CĂRBUNESCU CLINICAL RESEARCH SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Cărbunescu Clinical Research Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Cărbunescu Clinical Research Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Cărbunescu Clinical Research Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Cărbunescu Clinical Research Srl - CUI 28044821
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
104
103
101
99
98
96
94
94
94
93
Current Assets
110.957
39.356
12.718
13.797
14.159
9.203
9.033
13.676
8.361
7.979
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
100.502
27.108
8.360
8.206
8.047
7.745
7.557
7.182
7.159
7.121
Cash
10.455
12.248
4.357
5.591
6.112
1.458
1.476
6.494
1.201
859
Shareholders Funds
115.674
39.932
8.056
9.332
10.221
4.317
2.498
4.853
986
569
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
806
4.891
4.763
4.565
4.035
4.982
6.629
8.917
7.469
7.504
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
7.979 euro in 2024 which includes Inventories of
0 euro, Receivables of
7.121 euro and cash availability of
859 euro.
The company's Equity was valued at
569 euro, while total Liabilities amounted to
7.504 euro.
Equity decreased by -411 euro, from 986 euro in 2023, to 569 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Cărbunescu Clinical Research Srl